Compare Quest Diagnostics Inc (DGX) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs iShares Silver Trust — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while iShares Silver Trust trades at $52.59. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while iShares Silver Trust pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| DGX | SLV | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | — |
52-Week High | $216.02 | $105.57 |
52-Week Low | $166.42 | $33.32 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
SLV (iShares Silver Trust) is trading at $52.16, down 3.32% amid broader precious metals weakness. The ETF shows bearish technical signals with moving averages and ADX indicators pointing lower, though RSI readings suggest potential oversold conditions. Recent news highlights silver's dual role as both industrial metal and store of value, with prices down 17.8% year-to-date according to Barron's (July 13, 2026).
Silver's outlook remains challenged by inflation fears and Fed policy uncertainty, though some analysts see potential for recovery to $55-60 range (StoneX Q3 Outlook, July 10, 2026). Key risks include dollar strength, industrial demand fluctuations, and ongoing geopolitical tensions affecting precious metals markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
